Regenxbio Inc
(FRA:RB0)
€
7.05
0 (0%)
Market Cap: 350.57 Mil
Enterprise Value: 186.24 Mil
PE Ratio: 0
PB Ratio: 1.29
GF Score: 59/100 Regenxbio Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023 / 05:30PM GMT
Release Date Price:
€18.9
(+1.07%)
Matt Galle
(Trades, Portfolio), Inc. - Moderator
Good afternoon, everyone. Welcome to the Jefferies Global Healthcare Conference. My name is Matt Galle, part of the Jefferies Healthcare Investment Banking team.
It's my pleasure to introduce Ken Mills, President and CEO, REGENXBIO, to give the presentation today. Thank you.
Ken Mills
REGENXBIO Inc. - President, CEO
Thanks, Matt. Thanks to all the folks at Jefferies, the organizers, and also Matt Kim on the banking team, who's always a strong advocate for us at for REGENXBIO. Start here with the mention of forward-looking statements. There may be some statements that I make about future projections about operations or REGENXBIO today, to the extent that you need any further clarification on these
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot